These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19151792)

  • 1. Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.
    Jacobson P; El-Massah SF; Rogosheske J; Kerr A; Long-Boyle J; DeFor T; Jennissen C; Brunstein C; Wagner J; Tomblyn M; Weisdorf D
    Bone Marrow Transplant; 2009 Jul; 44(2):113-20. PubMed ID: 19151792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.
    Windreich RM; Goyal RK; Joshi R; Kenkre TS; Howrie D; Venkataramanan R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):682-689. PubMed ID: 26740371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.
    Harnicar S; Ponce DM; Hilden P; Zheng J; Devlin SM; Lubin M; Pozotrigo M; Mathew S; Adel N; Kernan NA; O'Reilly R; Prockop S; Scaradavou A; Hanash A; Jenq R; van den Brink M; Giralt S; Perales MA; Young JW; Barker JN
    Biol Blood Marrow Transplant; 2015 May; 21(5):920-5. PubMed ID: 25687796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of mycophenolic acid exposure to clinical outcome after hematopoietic cell transplantation.
    Jacobson P; Rogosheske J; Barker JN; Green K; Ng J; Weisdorf D; Tan Y; Long J; Remmel R; Sawchuk R; McGlave P
    Clin Pharmacol Ther; 2005 Nov; 78(5):486-500. PubMed ID: 16321615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation.
    Giaccone L; McCune JS; Maris MB; Gooley TA; Sandmaier BM; Slattery JT; Cole S; Nash RA; Storb RF; Georges GE
    Blood; 2005 Dec; 106(13):4381-8. PubMed ID: 16144801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics-based optimal dose-exploration of mycophenolate mofetil in allogeneic hematopoietic stem cell transplantation.
    Okamura A; Yamamori M; Shimoyama M; Kawano Y; Kawano H; Kawamori Y; Nishikawa S; Minagawa K; Yakushijin K; Katayama Y; Sakaeda T; Hirai M; Matsui T
    Int J Hematol; 2008 Jul; 88(1):104-110. PubMed ID: 18473127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
    Bhatia M; Militano O; Jin Z; Figurski M; Shaw L; Moore V; Morris E; Tallamy B; van deVen C; Ayello J; Baxter-Lowe L; Satwani P; George D; Bradley MB; Garvin J; Cairo MS
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):333-43. PubMed ID: 19835971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.
    McDermott CL; Sandmaier BM; Storer B; Li H; Mager DE; Boeckh MJ; Bemer MJ; Knutson J; McCune JS
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1159-66. PubMed ID: 23660171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
    Haentzschel I; Freiberg-Richter J; Platzbecker U; Kiani A; Schetelig J; Illmer T; Ehninger G; Schleyer E; Bornhäuser M
    Bone Marrow Transplant; 2008 Jul; 42(2):113-20. PubMed ID: 18362900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous mycophenolate mofetil in allogeneic hematopoietic stem cell-transplanted Japanese patients.
    Kurata K; Yakushijin K; Okamura A; Yamamori M; Ichikawa H; Sakai R; Mizutani Y; Kakiuchi S; Miyata Y; Kitao A; Kawamoto S; Matsuoka H; Murayama T; Minami H
    Cancer Chemother Pharmacol; 2018 May; 81(5):839-846. PubMed ID: 29511796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
    Bornhäuser M; Schuler U; Pörksen G; Naumann R; Geissler G; Thiede C; Schwerdtfeger R; Ehninger G; Thiede HM
    Transplantation; 1999 Feb; 67(4):499-504. PubMed ID: 10071016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
    Nash RA; Johnston L; Parker P; McCune JS; Storer B; Slattery JT; Furlong T; Anasetti C; Appelbaum FR; Lloid ME; Deeg HJ; Kiem HP; Martin PJ; Schubert MM; Witherspoon RP; Forman SJ; Blume KG; Storb R
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):495-505. PubMed ID: 15983549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.
    Jenke A; Renner U; Richte M; Freiberg-Richter J; Platzbecker U; Helwig A; Thiede HM; Schäfer-Eckart K; Ehninger G; Bornhäuser M
    Clin Transplant; 2001 Jun; 15(3):176-84. PubMed ID: 11389708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate pharmacokinetics and association with response to acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.
    Jacobson PA; Huang J; Wu J; Kim M; Logan B; Alousi A; Grimley M; Bolaños-Meade J; Ho V; Levine JE; Weisdorf D
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):421-9. PubMed ID: 19925875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.
    Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
    Clin Chem; 2001 Jan; 47(1):88-94. PubMed ID: 11148182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.
    Saint-Marcoux F; Royer B; Debord J; Larosa F; Legrand F; Deconinck E; Kantelip JP; Marquet P
    Clin Pharmacokinet; 2009; 48(10):667-75. PubMed ID: 19743888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics-based optimal dose prediction of donor source-dependent response to mycophenolate mofetil in unrelated hematopoietic cell transplantation.
    Wakahashi K; Yamamori M; Minagawa K; Ishii S; Nishikawa S; Shimoyama M; Kawano H; Kawano Y; Kawamori Y; Sada A; Matsui T; Katayama Y
    Int J Hematol; 2011 Aug; 94(2):193-202. PubMed ID: 21751082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.
    van Hest RM; Doorduijn JK; de Winter BC; Cornelissen JJ; Vulto AG; Oellerich M; Löwenberg B; Mathot RA; Armstrong VW; van Gelder T
    Ther Drug Monit; 2007 Jun; 29(3):353-60. PubMed ID: 17529894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.